Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.10.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2018
Dec. 31, 2017
Assets    
Equity method investments $ 434,463 $ 522,615
Government receivables 503,746 519,485
Commercial receivables 577,406 473,452
Receivables held-for-sale 16,250 19,081
Real estate 361,775 340,824
Investments 162,188 151,209
Cash and cash equivalents 34,423 57,274
Other assets 204,863 166,232
Total Assets 2,295,114 2,250,172
Liabilities:    
Accounts payable, accrued expenses and other 32,822 25,645
Deferred funding obligations 83,487 153,308
Credit facilities 289,293 69,922
Non-recourse debt (secured by assets of $1,411 million and $1,545 million, respectively) 1,096,240 1,210,861
Convertible notes 146,658 147,655
Total Liabilities 1,648,500 1,607,391
Stockholders’ Equity:    
Preferred stock, par value $0.01 per share, 50,000,000 shares authorized, no shares issued and outstanding 0 0
Common stock, par value $0.01 per share, 450,000,000 shares authorized, 52,728,818 and 51,665,449 shares issued and outstanding, respectively 527 517
Additional paid in capital 791,383 770,983
Accumulated deficit (151,834) (131,251)
Accumulated other comprehensive income (loss) 3,024 (1,065)
Non-controlling interest 3,514 3,597
Total Stockholders’ Equity 646,614 642,781
Total Liabilities and Stockholders’ Equity $ 2,295,114 $ 2,250,172